A one-time shot of a gene-editing treatment has shown to be remarkably effective in patients suffering from genetic angioedema, a mysterious, sometimes horrifying, inherited disease. In a phase 3 trial, the treatment decreased attack rates by 87 percent relative to placebo, and more than half of treated patients experienced...